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Background: Bio-active trace metals have been identiﬁed in respiratory tract secretions of subjects with lung disease and may potentially inﬂuence
bacterial virulence, inﬂammation and disease severity. We measured a diverse range of metal ions in sputum samples from subjects with CF and
non-CF bronchiectasis (NCFB) compared to healthy controls and examined their relationship to airway inﬂammation, disease severity and the
presence of bacterial pathogens.
Methods: We studied 45 subjects with CF, 8 with NCFB and 8 healthy controls. Metal concentrations were measured in sputum supernatant by
inductively-coupled plasma mass spectrometry and correlated with sputum inﬂammatory cell counts, lactate dehydrogenase (LDH) and interleukin
(IL)-8 concentrations, atmospheric particulate matter, lung function, clinical status and participant demographics.
Results: Sputum from subjects with CF and NCFB contained increased concentrations of magnesium, calcium, iron and zinc. Metal ion
concentrations correlated positively with LDH levels. The concentrations of magnesium, iron and zinc positively correlated with IL-8. A sub-group
of CF subjects with severe lung disease demonstrated increased sputum molybdenum concentrations.
Conclusion: Elevated concentrations of sputum metal ions appear to be associated with cell/tissue necrosis and inﬂammation in subjects with CF
and NCFB. Sputum molybdenum concentrations may be a biomarker of severe CF airway disease.
© 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic Fibrosis; Bio-metals; Inﬂammation; Cellular injury1. Introduction
The majority of individuals with cystic fibrosis (CF) will die
prematurely from complications associated with chronic pulmo-
nary sepsis [1]. Intermittent airway infection and inflammation in
CF begins in infancy, resulting in early onset bronchiectasis in
many children [2]. By adulthood, chronic, poly-microbial infection
is established, in which Pseudomonas aeruginosa is the dominant
pathogen in more than eighty percent of patients [3]. The host
immune response to infection in CF is intense and persistent, but⁎ Corresponding author at: Department of ThoracicMedicine, The Prince Charles
Hospital, Rode Road, Chermside, Brisbane, Queensland 4032, Australia. Tel.: +61 7
3139 6770; fax: +61 7 3139 5630.
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http://dx.doi.org/10.1016/j.jcf.2013.12.001is ineffective in clearing bacterial infection from the airways and
contributes to local tissue destruction through the generation of
proteolytic enzymes and reactive oxygen species (ROS) [4].
As pulmonary disease progresses, plugging of the distal airways
by dehydrated sputum creates micro-aerobic or frankly anaerobic
pockets, with low pH and altered nutrient availability [5,6]. The
highly abnormal environment within these regions drives pheno-
typic adaptation and alters the virulence of the incumbent bacteria,
favouring pathogens capable of survival in low oxygen environ-
ments [6].
Bio-active trace metals (biometals) are essential co-factors in a
wide range of human and bacterial enzyme systems; however,
strict regulation of their bioavailability is essential to prevent
toxicity [7]. A limited number of previous studies in patients with
CF, non-CF bronchiectasis (NCFB) and chronic bronchitis haveby Elsevier B.V. All rights reserved.
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centrations in airway secretions and have postulated that these
metals may influence disease severity [8,9].
There is increasing interest in Fe in the CF lung. In vitro studies
demonstrate that Fe strongly influences the ability of P. aeruginosa
to form co-dependent bacterial communities (biofilms), which
represent the major barrier to the eradication of established air-
way infection. Manipulation of Fe availability has therefore been
proposed as a novel therapeutic strategy for the treatment of
chronic P. aeruginosa infection [10,11]. An observational study
by Gray and colleagues has previously demonstrated increased
concentrations of Zn and Cu in the CF lung [8], and in sepa-
rate in vitro studies these metals have been shown to induce P.
aeruginosa resistance to carbapenem antibiotics [12]. From the
host perspective, airway Fe and other redox active biometals may
catalyse the production of ROS and promote inflammation [13].
Conversely, Cu and Zn are key components of airway anti-
inflammatory superoxide dismutases (SODs) [14]. The origin of
airwaymetal ions has not been determined, with potential sources
including vascular leak, channelopathies and release from ne-
crotic airway cells, or the bacteria themselves.
In this study, we expand on previous work by examining a
more diverse range of biometals in expectorated sputum samples
from patients with CF and NCFB. Sputum biometal concentra-
tions are compared to those in healthy controls, and correlated
with sputum lactate dehydrogenase (LDH) as an index of lo-
cal tissue necrosis and interleukin (IL)-8 as a marker of airway
inflammation and host immune response. To examine the influence
of infection and clinical status on biometal concentration, we
included a sub-group of patients with CFwhowere not infectedwith
P. aeruginosa and followed a group of P. aeruginosa infected
patients through treatment of a pulmonary exacerbation with a
course of intravenous antibiotic therapy.
Calcium (Ca), magnesium (Mg), manganese (Mn), Zn and Cu
were selected for their importance in inflammatory pathways
[13–15]. Molybdenum (Mo) and Fe were selected for their po-
tential importance to bacterial virulence and anaerobic respiration
[9,16]. Finally, nickel (Ni) and lead (Pb) were included as potential
indicators of environmental contamination [17,18].Table 1
Participant demographics.
Normal (n = 8)
Age (years) 57 (7)
Sex (M:F) 6:2
FEV1 % predicted 106 (10)
FVC % predicted 110 (16)
BMI n/a
Airway pathogens (n, %)
–Pseudomonas aeruginosa –
–MSSA –
–Aspergillus spp. –
–MRSA –
–Burkholderia spp. –
–Haemophilus influenzae –
Values reported as mean (standard deviation) unless otherwise stated, M:F: Male:F
methicillin sensitive Staphylococcus aureus, MRSA: methicillin resistant Staphyloc2. Methods
2.1. Participants and sample collection
Participants were recruited from The Prince Charles Hospital,
Queensland and Royal Hobart Hospital, Tasmania, Australia. Insti-
tutional human research and ethics committee approval was gained
from both sites (HREC2008:2885 and H0009813 respectively).
Sixty-seven spontaneously expectorated sputum samples were
collected from 45 subjects with CF and a single sputum sample
was collected from eight subjects with NCFB. Induced sputumwas
collected from eight healthy control subjects following inhalation
of nebulised 4.5% hypertonic saline. For cross-sectional analyses,
the initial sputum sample collected from each subject was used.
Eleven subjects with CF provided samples at several time-points
during intravenous antibiotic treatment of a pulmonary exacerbation.
Participant demographics, including infecting pathogens were
recorded (Table 1). None of the participants reported regular
tobacco smoking.
2.2. Sputum processing
Sputum plugs free of salivary contamination were separated
from the expectorated sputum samples and homogenised with
dithiothreitol as previously described [19]. Homogenised sam-
ples were diluted with phosphate buffered saline (dilution factor
1:10) and centrifuged to pellet cells. The cell free supernatant was
removed and stored at−80 °C for later batch analysis of biometals.
The cell pellet was resuspended and total inflammatory cell count
(TCC) performed using standard methodology [19].
2.3. Inductively coupled plasma mass-spectrometry (ICP-MS)
analysis
To prepare samples for ICP-MS, 500 μL of sputum super-
natant was digested overnight in an acid-cleaned tube containing
500 μL of 3 M double-distilled nitric acid (HNO3) and 1 mL of
an internal standard spike solution (6He, 61Ni, 103Rh, 115In, 187Re
and 209Bi). Digested samples were diluted to 10 mL with 0.3 MCF (n = 45) Non-CF bronchiectasis (n = 8)
29 (12) 60 (10)b
28:17 4:4
53 (23)a 33 (15)c
65 (21)a 61 (6)c
21 (3)b 25 (4)d
33 (73%) 6 (75%)
16 (36%) –
9 (20%) 2 (25%)
2 (4%) –
3 (6%) –
1 (2%) 1 (13%)
emale ratio, data unavailable for aone, btwo, cthree, and dfour subjects, MSSA:
occus aureus, spp.: species. BMI: Body mass index. n/a: not available.
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machine. Four replicates per sample were averaged for the final
calculation. For calibration and to establish recovery rates, stan-
dard reference materials W2 and SLRS5 and multi-element stan-
dards were analysed at the beginning and the end of the run.
Internal standards were used to correct for internal drift. A monitor
solution, used to correct for external drift, and an instrument blank
solution, used to monitor baseline drift and memory effects, were
analysed at regular intervals throughout the run.
2.4. LDH and IL-8 measurement
LDH activity was determined in thawed sputum superna-
tants warmed to 37 °C using a LDH colorimetric assay kit
(Abcam Inc., Cambridge, MA) according to the manufacturer's
protocol. IL-8 (BioLegend, USA) concentration was measured
according to the manufacturer's protocol with a detection range
between 31.25 and 4000 pg/mL. Each sample was diluted as
necessary to fall in the linear range and assayed in duplicate.
2.5. Air quality assessment
To examine whether atmospheric pollutants potentially
contributed to sputum metal concentrations, we recorded the
level of atmospheric particulate matter 10 μm or smaller (PM10)
as reported by the Queensland Department of Environment and
Heritage Protection (http://www.ehp.qld.gov.au/air/data/search.
php) for the city of Brisbane on the day a sputum sample was
collected. These data were available for subjects sampled through
the Prince Charles Hospital, but no similar data were available for
Tasmanian participants.
2.6. Statistical analysis
Between-group differences in continuous variables were
analysed by independent sample t-test, analysis of covariance,
Mann–Whitney U or Kruskal–Wallis H test, depending on num
ber of independent groups and normality of the data. Pearson's
correlation was used to examine relationships between lung func
tion, TCC, IL-8, LDH, PM10 and biometal concentrations. A
p-value b 0.05 was considered to represent statistical signifi-
cance. Data analysis was performed using PASW, Version 18.0
(SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Cross-sectional comparisons
Sixty-one samples (8 normal, 8 NCFB, 45 CF) were included
in the cross-sectional analysis. Sputum from subjects with CF and
NCFB demonstrated a high TCC and contained significantly
higher concentrations of Mg, Ca, Fe and Zn compared to healthy
controls (Table 1).
Sputum metal concentrations were compared to published
data on biometal concentration in normal serum, whole blood
and pleural fluid (Table 2) [20–24]. Sputum from subjects with
CF and NCFB contained higher metal concentrations thanserum and pleural fluid (except for Cu). Sputum from healthy
controls contained lower concentrations of biometals than serum,
pleural fluid and whole blood (except for Pb which was higher
than in serum and pleural fluid).
In patients with CF, two distinct cohorts of subjects were
detected with and without significant concentrations of Mo
(Fig. 1). Subjects with elevated Mo concentrations had lower
FEV1 % predicted, but also lower TCC (Supplemental Table 1).
Six subjects with NCFB and 33 with CF were infected with
P. aeruginosa. CF subjects infected with P. aeruginosa had
lower lung function (Median FEV1 % predicted 38% v 71%,
p b 0.01) and higher sputum concentration of IL-8 (165 v
70 ng/mL, p b 0.01), Ca (105 v 74 mg/L, p b 0.01) and Mg
(22 v 47 mg/L, p b 0.05) compared to subjects without
P. aeruginosa infection; however TCCs and levels of other
measured metals were not significantly different (Supple-
mental Table 2).
3.2. Relationship between biometals, LDH, IL-8 and PM10
within samples
A correlation analysis, including all sputum samples demon-
strated that the concentrations of Mg, Ca, Fe, Zn and Cu were
all strongly correlated with one another (Table 3). Conversely,
no relationship was seen between concentrations of Pb, Mo
or Ni. In sputum samples from subjects with CF and NCFB,
both LDH and IL-8 concentrations positively correlated with
the concentration of Mg, Fe and Zn, and LDH alone correlated
with Ca and Cu concentrations (Table 3).
Comparative PM10 data was available for 43 sputum
samples from 23 CF subjects. There was no correlation
between PM10 and metal concentrations in sputa on the day
of collection (Table 3).
3.3. Sputum biometals during pulmonary exacerbations
Four CF subjects had increased sputum Pb levels on ad-
mission, which fell to trace levels during the course of the
admission. Sputum Fe concentration increased during treatment
in three subjects, of which, two received intercurrent iron in-
fusions to correct severe iron deficiency. There was no con-
sistent change in sputum concentrations of the other metals
during treatment of a pulmonary exacerbation (Supplemental
Fig. 1).
4. Discussion
This work provides important new insights into the inflam-
matory milieu present in the lungs of patients with CF and
NCFB. A diverse range of biometals were present in the spu-
tum of subjects with these suppurative lung diseases, several of
which have the potential to significantly influence both host
immunity and bacterial virulence [25].
Defining the importance of the biometals we detected in
sputum and how these metals relate to lung disease severity will
advance our understanding of the lung micro-environment in
diseases characterised by chronic bacterial infection.
Table 2
Comparison of sputum inflammatory markers and biometals in healthy controls, CF and non-CF bronchiectasis.
Normal (n = 8) CF (n = 45) NCFB (n = 8) p-Valuea Pleural fluid [21] Serum [Reference] Blood [Reference]
CF NCFB
TCC (10^6 cell/mL) 0 (0–1) 12 (4–21) 24 (12–35) b0.001 b0.01
LDH (mU/mL) 39 (0–95)c 50 (1–247)e 13 (3–1657)b 0.5 0.5
IL-8 (ng/mL) 28 (15–64)c 135 (84–279)d 103 (13–292)b b0.01 0.2
Mg (mg/L) 4 (2–7) 30 (19–44) 33 (27–39) b0.001 b0.01 18 22 [21]
Ca (mg/L) 45 (28–58) 102 (76–123) 124 (78–156) b0.001 b0.01 71 96 [21]
Mn (μg/L) 5 (2–9) 6 (4–17) 6 (4–10) 0.3 0.7 1 1.0 [21] 12 [22]
Fe (μg/L) 0 (0–37) 797 (398–1292) 1075 (862–1324) b0.001 b0.01 n/a 4690 [24] 476,000 [22]
Ni (μg/L) 12 (1–60) 5 (0–23) 26 (2–99) 0.3 0.7 n/a 2.2 [25] 2.7 [22]
Zn (μg/L) 179 (103–597) 1285 (678–1811) 537 (401–838) b0.001 b0.05 283 474 [21] 5800 [22]
Cu (μg/L) 106 (55.3–196) 173 (128–257) 226 (130–314) 0.1 0.07 530 1189 [21] 830 [22]
Mo (μg/L) 0 (0) 0 (0–181) 0 (0) b0.05 0.4 1 1.2 [21] 0.9 [22]
Pb (μg/L) 9 (4–21) 3 (1–6) 2 (1–5) b0.05 b0.05 6 1.3 [21] 26 [25]
Values reported as median (interquartile range), acompared to normal subject byMann–Whitney U test, data unavailable on bone patient, cthree patients, dfour patients, and
esix patients, mg/L: milligrammes per litre, μL/L: microgrammes per litre, ng/mL: nanogrammes per millilitre, CF: Cystic fibrosis, NCFB: non-CF bronchiectasis.
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provide information that will be relevant to the development of
in vitro infection models and potentially, identify targets for
novel therapies [11].
The strong positive correlation between the concentrations
of Ca, Mg, Fe, Zn and Cu suggests that these metals may
originate from a common disease process. LDH has previously
been identified as a surrogate marker of pulmonary tissue da-
mage and the positive correlation between several of the bio-
metals detected and LDH levels supports cell injury as a probable
contributor to the presence of some of these biometals [26]. The
concentration of sputum biometals more closely represents levels
seen in whole blood compared to serum (Table 1) and several
metals (Mg, Fe and Zn) correlated positively with the concentra-
tion of pro-inflammatory IL-8, adding further support to the
hypothesis that release of these metals is associated with local
tissue damage.
Consistent with previous studies, CF subjects infected with
P. aeruginosa had worse lung function and higher sputum IL-8
concentration, than their non-infected counterparts [27]. Surp-
risingly, there was a trend towards lower TCCs in the P. aeruginosaFig. 1. Concentration of molybdenum in sputum samples.infected patients; however, sputum concentrations of Mg and Ca
were significantly higher, which may again support a hypothesis
that these metals are released from necrotic immune cells in the
setting of heightened inflammation. From our results, it is not
possible to determine whether the biometals originated from
injured lung tissue or from luminal inflammatory cells and in-
vestigation of metal levels within the airway wall or lung paren-
chyma is required to address this question.
Other potential sources of biometals in sputum should be
considered, including micro-vascular leakage, cell membrane
channelopathies and contamination from inhaled particulates.
We have previously reported increased concentrations of micro-
albumin in CF sputa, which may suggest microvascular leakage
is contributory [28], but, sputum biometal levels exceeded those
reported in serum, which argues against this being the sole ex-
planation [21–23].
CFTR-mutant airway epithelial cells (AECs) appear to “leak” Fe
in vitro, which in-turn promotes growth of P. aeruginosa on their
apical cell surface membrane, and suggests specific channelopathies
may contribute to airway metal accumulation [29]. For example,
divalent metal-ion transporter (DMT)-1 is important in airway Fe
detoxification and, in DMT-1 deficient rats, Fe accumulates in the
airways, resulting in increased oxidative stress and inflammation
[30]. This observation is important, as abnormal function of metal
transport channels may be amenable to therapeutic manipulation to
limit the availability of metals to pathogenic bacteria.
The contribution of inhaled particulate matter to sputum metal
concentrations was assessed by measurement of sputum of Pb and
Ni concentrations and correlation of sputum biometal concentra-
tions to atmospheric PM10 levels on the day of sample collection.
Lead was detectable in the sputa of four CF subjects on admission
to hospital, but not at subsequent time-points, raising the possibility
that this metal was environmentally derived (e-Fig. 1). However,
PM10 values did not correlate with sputum metal content in any of
the subjects. Furthermore, Pb and Ni concentrations in subjects
with CF and NCFB were not significantly different to those found
Table 3
Correlation co-efficients of biometals in all sputum samplesa,b,c.
Ca Mn Fe Zn Cu FEV1 % predicted TCC IL-8 LDH PM10
Mg 0.89d 0.13 0.79d 0.75d 0.42d −0.20 0.05 0.42d 0.44d 0.05
Ca – 0.15 0.80d 0.67d 0.49d −0.16 −0.02 0.23 0.33d 0.11
Mn – – 0.29d 0.12 0.06 0.28e −0.13 0.15 −0.14 −0.14
Fe – – – 0.75d 0.47d −0.11 −0.08 0.39d 0.40d 0.03
Zn – – – – 0.46d −0.18 0.02 0.38d 0.39d 0.03
Ni – – – – – −0.30e −0.01 0.03 0.11 0.03
Cu – – – – – −0.20 −0.15 0.23 0.32d 0.04
Mo – – – – – −0.38d −0.31 0.18 0.02 −0.03
Pb – – – – – −0.08 −0.13 −0.19 −0.10 −0.03
Values: Pearson's correlation-r values, dp b 0.01, ep b 0.05. aCorrelations of Ni, Mo and Pb with other metals were not significant and are not included. bCorrelations
with FEV1 % predicted, TCC, IL-8 and LDH do not include healthy control data.
cCorrelations with PM10 are based on 43 samples obtained from subjects with CF
recruited from Queensland, where comparative air-quality data was available. FEV1 % predicted: percentage predicted forced expiratory volume in one second. TCC:
total inflammatory cell count. IL: interleukin. LDH: lactate dehydrogenase. PM10: Particulate matter 10 μm or smaller in diameter.
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that environmental exposure to metals has minimal impact on
sputum biometal content.
An important new finding is the identification of a distinct
group of CF subjects with “elevated” concentrations of sputum
Mo. Subjects with elevated Mo overall had more severe lung
disease and a sub-group had CF related liver disease.Molybdenum
is able to cycle between reduced (Mo4+) and oxidised (Mo6+)
states under normal physiological conditions and facilitates the
transfer of atomic oxygen between substrates in anoxic environ-
ments, which makes it essential to virtually all forms of life [16].
In humans, Mo co-factored proteins are incorporated into the
flavoenzymes, which catalyse critical detoxification pathways
[31]. Increased serum Mo concentrations have been reported in
patients with liver disease, a finding not inconsistent with our
sputum findings, although we did not assess Mo levels in serum to
confirm a corresponding increase in systemic levels [32]. In
bacteria, Mo is an essential component of nitrate reductase, which
catalyses the denitrification of nitrate during anaerobic respiration
[16]. Whilst P. aeruginosa is an aerobic bacterium, it can thrive
under microaerobic and anaerobic conditions through the utilisation
of nitrogen sources [33]. Under anaerobic conditions, P. aeruginosa
increases the production of Mo containing proteins and mutant
strains that are unable to incorporate Mo have attenuated virulence
[34]. The evidence for anaerobic bacterial respiration in the diseased
CF lung is compelling, with the presence of a variety of obligate
anaerobes identified in addition to P. aeruginosa [33,35]. It is
biologically plausible that airway Mo may promote anaerobic
respiration in resident bacteria, but this requires further inves-
tigation. Interestingly, TCC was lower in the elevated Mo group,
which as discussed previously, may suggest immune cell necrosis
is contributing towards airway Mo. Longitudinal studies, which
correlate Mo concentrations with, clinical status (stable versus
pulmonary exacerbation), lung function decline, infecting patho-
gens, airway inflammation and serum Mo levels are required to
further define the relevance to bacterial virulence and outcomes
in patients with CF.
Increased Fe in the sputum of patients with CF has been
demonstrated in several studies [9,28,36,37]. Iron poses a risk
to the lung through generation of toxic hydroxyl radicals and
oxidative stress via Fenton chemistry and, as previously discussed,Fe has been shown to influence P. aeruginosa behaviour in vitro
[10]. Furthermore, Fe concentrations positively correlate with P.
aeruginosa colony counts in the sputum of patients with CF
confirming its importance in vivo [9].
Magnesium has generally been considered to be anti-
inflammatory [38], but animal studies have shown that it may
inhibit phagocytosis and impair the oxidative burst capacity of
neutrophils, which will be detrimental in the setting of chronic
infection [39]. From a bacterial perspective, conflicting in vitro
studies suggest Mg may inhibit formation of new P. aeruginosa
biofilms, but protect established biofilms from disruption [40].
Calcium was also present in high concentrations in sputa from
patients with CF and NCFB, and in vitro studies have demons-
trated that Ca-dependent signalling enhances P. aeruginosa cell
adherence, including adherence to AECs [41]. Additionally, culture
of P. aeruginosa in medium supplemented with 10 mM Ca2+
resulted in a 10 fold increase in biofilm thickness, and up-regulation
of virulence factors, including a three-fold increase in production
of pyocyanin [42]. Pyocyanin itself, which is an important P.
aeruginosa exotoxin, disturbs AEC Ca homeostasis, which will
serve to further increase airway Ca concentrations [43].
The high concentration of Zn found in CF and, to a lesser
extent, NCFB sputa is consistent with a single, previous pub-
lication [8]. This finding is surprising given the high prevalence
of systemic Zn deficiency reported in CF, and may therefore
suggest selective Zn loss into the airways [18,44]. Human AEC
strongly expresses the anti-oxidant Cu–Zn-SOD and systemic
Zn deficiency increases airway inflammation and susceptibility
to oxidative stress [14]. Zinc co-factored metalloproteinases,
such as ADAM33, contribute to airway remodelling in res-
ponse to repeated insults [45]. In vitro and animal models
suggest Zn restores defective chloride transport by activating
alternative Ca-dependent chloride channels and Zn supplemen-
tation has been shown to be of modest benefit in reducing
antibiotic requirements in children with CF [44]. In bacteria, Zn
is an essential metal, but also potentially toxic and its uptake is
tightly regulated [12]. P. aeruginosa Zn uptake is regula-
ted by the operon CzcRS, which in the presence of Zn promotes
expression of the metal efflux pump CzcCBA. Additio-
nally, CzcRS down regulates OprD that confers resistance to
carbapenem antibiotics, suggesting an increase in Zn within the
294 D.J. Smith et al. / Journal of Cystic Fibrosis 13 (2014) 289–295airway may influence antibiotic susceptibility [12]. The net effect
on disease outcomes in CF and NCFB of increased airway Zn
concentrations remains uncertain, given the anti-inflammatory
properties versus potential promotion of antibiotic resistance, and
requires further investigation.
This study has a number of limitations. Studies of airway
pathology based on expectorated sputum are intrinsically associ-
ated with sampling variability and confounded by the possibility of
oropharyngeal contamination, but we were very careful to select
only airway plugs and salivary contamination with this practice is
minimal [46]. There were only a small number of healthy controls
and patients with NCFB, but our numbers are comparable with
earlier reports [8,36,37]. There was no change in sputum metal ion
concentrations during treatment of a pulmonary exacerbation,
suggesting that the measurement of metals has limited potential
as a biomarker of therapeutic response. However, patients who
provided serial samples were at the severe end of the disease
spectrum. These individuals often respond sub-optimally to anti-
biotic treatment, in terms of their clinical improvement, reduction
in bacterial numbers and inflammation, which may have limited
our ability to detect meaningful changes [46]. Future studies should
examine whether biometal concentrations fluctuate in response to
treatment in patients with milder disease, and also at a much earlier
time-point in the disease process, i.e. prior to the onset of infection.
Additionally, studies in subjects at an earlier disease time-point
may allow metal concentrations to be correlated with the presence
of different inflammatory cell types (i.e. neutrophils versusmacro-
phages), which is not possible in the adult subjects, with severe
disease, where airway inflammation is dominated by neutrophils.
Finally, analysis of the impact of specific bacterial infections, e.g.
MRSA and Burkholderia species, on biometal levels is limited by
the study size.
In summary, this is the most extensive analysis of sputum
biometals in patients with CF and NCFB undertaken to date.
The positive correlation between sputum LDH and biometal
concentrations suggests that local cell damage is associated
with airway metal content; however, whether local tissue injury
is the source or a consequence of the presence of redox active
biometals in the airway requires further investigation. A sub-
group of CF patients with severe lung disease were identifiable
by the presence of increased Mo in their sputum. It is likely that
the complex composition of the biometals milieu in the lung
strongly influences the behaviour of both the host immune
response as well as bacterial pathogens. Mechanistic studies are
required to establish the source of the metals detected and to
determine their relevance to oxidative stress, impaired immune
function and the promotion of bacterial virulence. Novel thera-
peutic interventions that modulate the availability of these bio-
metals may reduce airway infection and substantially impact on
disease progression.
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